Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Blood and Bone Loser.

× No keyword cloud information.

9 in total

1. Randomized trial of intravenous iron-induced hypophosphatemia.

Authors: Myles Wolf; Glenn M Chertow; Iain C Macdougall; Robert Kaper; Julie Krop; William Strauss
Journal: JCI Insight Date: 2018-12-06

2. Effects of ferric carboxymaltose on markers of mineral and bone metabolism: A single-center prospective observational study of women with iron deficiency.

Authors: Rebecca Frazier; Alexander Hodakowski; Xuan Cai; Jungwha Lee; Anaadriana Zakarija; Brady Stein; Valentin David; Myles Wolf; Tamara Isakova; Rupal Mehta
Journal: Bone Date: 2020-07-28 Impact factor: 4.398

Review 3. Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome.

Authors: John A Glaspy; Myles Wolf; William E Strauss
Journal: Adv Ther Date: 2021-05-30 Impact factor: 3.845

4. Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status.

Authors: Wendy Fang; Rachel Kenny; Qurat-Ul-Ain Rizvi; Lawrence P McMahon; Mayur Garg
Journal: BMC Gastroenterol Date: 2020-06-10 Impact factor: 3.067

5. Hypophosphatemia after high-dose intravenous iron treatment in patients with inflammatory bowel disease: Mechanisms and possible clinical impact.

Authors: Trond Espen Detlie; Jonas Christoffer Lindstrøm; Marte Eide Jahnsen; Elisabeth Finnes; Heinz Zoller; Bjørn Moum; Jørgen Jahnsen
Journal: World J Gastroenterol Date: 2021-05-07 Impact factor: 5.742

9. A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose.

Authors: Giuseppe Rosano; Ingolf Schiefke; Udo-Michael Göhring; Vincent Fabien; Stefano Bonassi; Jürgen Stein
Journal: J Clin Med Date: 2020-11-06 Impact factor: 4.241

9 in total

Blood and Bone Loser.

1. Randomized trial of intravenous iron-induced hypophosphatemia.

2. Effects of ferric carboxymaltose on markers of mineral and bone metabolism: A single-center prospective observational study of women with iron deficiency.

Review 3. Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome.

4. Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status.

5. Hypophosphatemia after high-dose intravenous iron treatment in patients with inflammatory bowel disease: Mechanisms and possible clinical impact.

6. Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose.

7. Osteomalacia as a Complication of Intravenous Iron Infusion: A Systematic Review of Case Reports.

8. High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment.

9. A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose.